NEW DELHI : With covid-19 pandemic entering into second year, pharmaceutical companies across the world are developing more than 300 vaccines against the coronavirus.
According to the latest update of landscape of novel coronavirus vaccines candidate development worldwide, compiled and maintained by WHO, 126 vaccines are in clinical development and 194 vaccines are in pre-clinical development stages.
While India has developed Covaxin and manufacturing covishield, several new vaccines are in the offing. The covid-19 vaccine tracker and landscape compiles detailed information of each covid-19 vaccine candidate in development by closely monitoring their progress through the pipeline.